跳至主要内容
临床试验/NCT00933621
NCT00933621已完成2 期

Intracoronary Injection of Autologous Bone Marrow Cells in Patients With Chronic Heart Failure: Five Years Follow up

Assaf-Harofeh Medical Center2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2003年4月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
8
试验地点
2
主要终点
Procedure success

研究概览

简要总结

The study aim is to evaluate the long term outcome of intra-coronary autologous bone marrow (BM) transplantation in patients with severe ischemic cardiomyopathy without the option for revascularization.

详细描述

Several studies have demonstrated the short term safety, feasibility and efficacy of cell transplantation in patients with advanced heart failure. There are no data about the long term outcome.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 88 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with evidence of hibernation and/or ischemia in at least 2 different myocardial segments underwent coronary angiography

排除标准

  • Idiopathic or non-ischemic cardiomyopathy
  • Other etiology for heart failure, history of past or current disease involving the bone marrow
  • Patients on dialysis
  • Positive serologic test for HIV, hepatitis B or C or any neoplastic or terminal disease

结局指标

主要结局

Procedure success

时间窗: 9 months

次要结局

  • Functional class improvement(9 months)

研究者

申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验

Intracoronary Injection of Autologous Bone Marrow... | 临床试验